Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Minority Interest (2022 - 2026)

Gyre Therapeutics has reported Minority Interest over the past 4 years, most recently at $36.3 million for Q4 2025.

  • Quarterly Minority Interest rose 3.33% to $36.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.3 million through Dec 2025, up 3.33% year-over-year, with the annual reading at $36.3 million for FY2025, 3.33% up from the prior year.
  • Minority Interest was $36.3 million for Q4 2025 at Gyre Therapeutics, up from $35.5 million in the prior quarter.
  • Over five years, Minority Interest peaked at $37.4 million in Q2 2025 and troughed at $29.7 million in Q4 2022.
  • The 4-year median for Minority Interest is $35.2 million (2024), against an average of $34.0 million.
  • Year-over-year, Minority Interest rose 0.28% in 2023 and then rose 17.82% in 2024.
  • A 4-year view of Minority Interest shows it stood at $29.7 million in 2022, then grew by 0.28% to $29.8 million in 2023, then increased by 17.82% to $35.1 million in 2024, then rose by 3.33% to $36.3 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Minority Interest are $36.3 million (Q4 2025), $35.5 million (Q3 2025), and $37.4 million (Q2 2025).